{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:34:01Z","timestamp":1787582041452,"version":"build-2736575974"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Glucocorticoid excess in Cushing disease (CD) leads to negative feedback suppression, resulting in Crooke's hyaline change (CC) of nontumorous pituitary corticotrophs. We aimed to determine the predictive value of CC of nontumorous corticotrophs in CD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The retrospective chart review study included patients with clinical, biochemical, radiologic and outcome data and evaluable histopathology specimens from pituitary surgery for CD. The main outcome was remission of CD, defined by clinical features, biochemical testing, and corticosteroid dependency.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 144 CD patients, 60 (50 women, mean age 43.6\u00b114) had clinical follow-up, biochemical data and histopathology specimens that included evaluable nontumorous adenohypophysis. Specimens from 50 patients (83.3%) demonstrated CC in nontumorous corticotrophs, and 10 (16.7%) had no CC (including 3 with corticotroph hyperplasia). One patient with CC was lost to follow-up and one without CC had equivocal outcome results. During a mean (SD) follow-up period of 74.9 months (61.0), recurrent or persistent disease was documented in 18 patients (31.0%), while 40 (69.0%) were in remission. In patients with CC, the remission rate was 73.5% (95% CI, 59.7%-83.7%) (36\/49), whereas it was 44.4% (95% CI, 18.9%-73.3%) (4\/9) in patients with no CC. The combination of serum cortisol &amp;gt;138 nmol\/L within a week of surgery coupled with absence of nontumorous CC greatly improved the prediction of recurrent or persistent disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>CC of nontumorous corticotrophs was observed in 83% of patients with CD, and most patients with CC experienced remission. Absence of CC in nontumorous corticotrophs may serve as a predictor of reduced remission in patients with CD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2021.620005","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T08:55:07Z","timestamp":1616057707000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Significance of Crooke's Hyaline Change in Nontumorous Corticotrophs of Patients With Cushing Disease"],"prefix":"10.3389","volume":"12","author":[{"given":"Amit","family":"Akirov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Larouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Shimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia L.","family":"Asa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Mete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Sawka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Gentili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen","family":"Ezzat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1210\/JC.2015-2493","article-title":"Crooke \u2018 s Changes in In Cushing\u2018s Syndrome Depends Susceptibility","volume":"100","author":"Oldfield","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-018-9521-z","article-title":"Immunohistochemical Biomarkers in Pituitary Pathology","volume":"29","author":"Asa","year":"2018","journal-title":"Endocr Pathol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.humpath.2020.10.004","article-title":"Cytokeratin profiles in pituitary neuroendocrine tumors","volume":"107","author":"Asa","year":"2021","journal-title":"Hum Pathol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/s0090-3019(99)00159-7","article-title":"Absence of Peritumoral Crooke \u2018 s Change is Associated with Recurrence in Surgically Treated Cushing \u2018 s Disease","volume":"53","author":"Hague","year":"2000","journal-title":"Surg Neurol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1043\/2010-0470-SAR1.1","article-title":"Protocol for the Examination of Specimens From Patients With Primary Pituitary Tumors","volume":"135","author":"Nose","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.2012.00599.x","article-title":"Clinicopathological Correlations in Pituitary Adenomas","volume":"22","author":"Mete","year":"2012","journal-title":"Brain Pathol"},{"key":"B7","doi-asserted-by":"crossref","DOI":"10.55418\/9781933477152","article-title":"Armed Forces Institute of Pathology Atlas of Tumor Pathology, Series 4, Fascicle 15","volume-title":"Tumors of the pituitary gland","author":"Asa","year":"2011"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing \u2018 s Syndrome : An Endocrine Society Clinical Practice Guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0921","article-title":"Long-term remission and recurrence rates in Cushing \u2018 s disease : predictive factors in a single-centre study","volume":"168","author":"Alexandraki","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1672","article-title":"Delayed Remission after Transsphenoidal Surgery in Patients with Cushing \u2018 s Disease","volume":"95","author":"Valassi","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1046\/j.0300-0664.2001.01444.x","article-title":"Undetectable postoperative cortisol does not always predict long-term remission in Cushing \u2018 s disease : a single centre audit *","volume":"56","author":"Yap","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02380.x","article-title":"Long-term remission rates after pituitary surgery for Cushing\u2019 s disease : the need for long-term surveillance","volume":"63","author":"Atkinson","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2234","article-title":"Brue T. A Combined Dexamethasone Desmopressin Test as an Early Marker of Postsurgical Recurrence in Cushing \u2018 s Disease","volume":"94","author":"Castinetti","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2013","article-title":"Late Recurrences of Cushing\u2019 s Disease after Initial Successful Transsphenoidal Surgery","volume":"93","author":"Patil","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-018-0902-6","article-title":"An early post-operative ACTH suppression test can safely predict short- and long-term remission after surgery of Cushing \u2018 s disease","volume":"21","author":"Uvelius","year":"2018","journal-title":"Pituitary"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1227\/neu.0b013e31822dda2c","article-title":"Transsphenoidal Surgery for Cushing Disease","volume":"79","author":"Fahlbusch","year":"1986","journal-title":"J R Soc Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.1.7093","article-title":"Incidence and Late Prognosis of Cushing\u2018s Syndrome : A Population-Based Study *","volume":"86","author":"Lindholm","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2112","article-title":"Mortality in Patients Treated for Cushing \u2018 s Disease Is Increased , Compared with Patients Treated for Nonfunctioning Pituitary Macroadenoma","volume":"92","author":"Dekkers","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1942","article-title":"Mortality and Morbidity in Cushing\u2019s Disease over 50 Years in Stoke-on-Trent, UK: Audit and Meta-Analysis of Literature","volume":"96","author":"Clayton","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-020-09646-x","article-title":"Structure, Function, and Morphology in the Classification of Pituitary Neuroendocrine Tumors: the Importance of Routine Analysis of Pituitary Transcription Factors","volume":"31","author":"Mete","year":"2020","journal-title":"Endocr Pathol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-014-0619-0","article-title":"Current status on histological classification in Cushing\u2018s disease","volume":"18","author":"Syro","year":"2015","journal-title":"Pituitary"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0208","article-title":"Outcomes and management of patients with Cushing\u2019s disease without pathological confirmation of tumor resection after transsphenoidal surgery","volume":"92","author":"Pouratian","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-018-03078-8","article-title":"The role of Crooke\u2019s changes in recurrence and remission after gamma knife radiosurgery","volume":"142","author":"Cordeiro","year":"2019","journal-title":"J Neurooncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02326","article-title":"Pathohistological classification of pituitary tumors : 10 years of experience with the German Pituitary Tumor Registry","volume":"156","author":"Saeger","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1212095","article-title":"Correlates of long-term hypocortisolism after transsphenoidal microsurgery for Cushing \u2018 s disease","volume":"107","author":"Futsch","year":"1999","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12300","article-title":"Evaluation of cushing\u2019s disease remission after transsphenoidal surgery based on early serum cortisol dynamics","volume":"80","author":"Costenaro","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031170","article-title":"Dynamics of serum cortisol levels after transsphenoidal surgery in a cohort of patients with cushing\u2019s disease","volume":"89","author":"Rollin","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/jns.2001.95.1.0001","article-title":"Serum cortisol response to transsphenoidal surgery for Cushing disease","volume":"95","author":"Simmons","year":"2001","journal-title":"J Neurosurg"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.620005\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T21:15:59Z","timestamp":1671657359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.620005\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,18]]},"references-count":28,"alternative-id":["10.3389\/fendo.2021.620005"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.620005","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,18]]},"article-number":"620005"}}